Pemigatinib’s a inhibitor that zeros in on the FGFR signaling pathway, FGFR2. It comes in tablet shape and it comes in doses of 4.5, 9, and 13.5 mg each.
The usual dose for taking this medication is 13.5 mg every day, for 14 days straight in a cycle that lasts 21 days. The med comes in bottles, each holding 14 tablets.
Reviews
There are no reviews yet.